Xiaomeng Dai

2.8k total citations · 1 hit paper
54 papers, 1.9k citations indexed

About

Xiaomeng Dai is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Xiaomeng Dai has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 15 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Xiaomeng Dai's work include Cancer Immunotherapy and Biomarkers (11 papers), Immune cells in cancer (7 papers) and Immunotherapy and Immune Responses (6 papers). Xiaomeng Dai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immune cells in cancer (7 papers) and Immunotherapy and Immune Responses (6 papers). Xiaomeng Dai collaborates with scholars based in China, United States and Hong Kong. Xiaomeng Dai's co-authors include Honglin Jin, Chao Wan, Kunyu Yang, Jonathan F. Lovell, Zi-Hao Liu, Bin Du, Yajie Sun, Jingshu Meng, Gang Wu and Jing Huang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaomeng Dai

53 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment

2024 68 citations Yuzhi Jin, Hui Ren et al. Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaomeng Dai China	24	826	644	504	466	433	54	1.9k
Jin Tao China	24	910 1.1×	502 0.8×	442 0.9×	342 0.7×	283 0.7×	52	1.9k
Qiong Wu China	28	1.1k 1.4×	833 1.3×	608 1.2×	197 0.4×	244 0.6×	97	2.3k
Amy Chang United States	13	738 0.9×	1.4k 2.2×	446 0.9×	460 1.0×	421 1.0×	28	2.3k
Zheng Zhu China	24	809 1.0×	973 1.5×	306 0.6×	813 1.7×	270 0.6×	78	2.2k
Yu Guo China	28	1.1k 1.3×	423 0.7×	636 1.3×	335 0.7×	427 1.0×	91	2.3k
Hongwei Lv China	16	1.2k 1.5×	332 0.5×	883 1.8×	281 0.6×	312 0.7×	30	2.1k
Wence Zhou China	18	584 0.7×	574 0.9×	452 0.9×	213 0.5×	285 0.7×	90	1.7k
Pingwei Xu China	20	1.1k 1.4×	366 0.6×	618 1.2×	511 1.1×	451 1.0×	23	2.1k
Shiji Fang China	21	828 1.0×	234 0.4×	490 1.0×	213 0.5×	252 0.6×	63	1.6k
Tao Fang China	25	1.0k 1.2×	457 0.7×	446 0.9×	308 0.7×	286 0.7×	53	1.8k

Countries citing papers authored by Xiaomeng Dai

Since Specialization

Citations

This map shows the geographic impact of Xiaomeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Dai more than expected).

Fields of papers citing papers by Xiaomeng Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Dai. The network helps show where Xiaomeng Dai may publish in the future.

Co-authorship network of co-authors of Xiaomeng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomeng Dai. A scholar is included among the top collaborators of Xiaomeng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomeng Dai. Xiaomeng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Bingzhu, Xiaomeng Dai, Jingya Li, et al.. (2025). Amplifying Anti‐Tumor Immune Responses via Mitochondria‐Targeting Near‐Infrared Photodynamic Therapy. Advanced Science. 12(33). e05525–e05525. 3 indexed citations

Zhang, Jia, Chun-Yu Lai, Xuanwen Bao, et al.. (2025). Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer. Journal of Nanobiotechnology. 23(1). 183–183. 4 indexed citations

Ли, Бин, Hangyu Zhang, Yang Gao, et al.. (2025). NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study. Cancer Immunology Immunotherapy. 74(11). 341–341. 1 indexed citations

Xie, Jindong, Bo Lin, Weihong Tian, et al.. (2024). Pan‐Cancer Single‐Cell and Spatial‐Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy. Advanced Science. 11(23). e2401061–e2401061. 35 indexed citations

Jin, Yuzhi, Hui Ren, Chun-Yu Lai, et al.. (2024). Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment. Biomaterials. 305. 122463–122463. 68 indexed citations breakdown →

Wang, Wenjun, Yu Liu, Dong Chen, et al.. (2024). “Convex Lens” of DNA damage: A nanomedicine enhances anti-PD-1 immunotherapy as immunogenic cell death inducer for “cold” melanoma. Nano Today. 61. 102598–102598. 1 indexed citations

Ye, Chanqi, Xiaoxiao Yan, Xiaomeng Dai, et al.. (2023). Biocompatible snowman-like tumor-targeting dimer nanoparticles for improved delivery efficiency and enhanced anti-tumor therapy. Chemical Engineering Journal. 474. 145766–145766. 9 indexed citations

Fu, Qihan, Yi Zheng, Weijia Fang, et al.. (2023). RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial. EClinicalMedicine. 63. 102175–102175. 46 indexed citations

Dai, Xiaomeng, Xuanwen Bao, Qihan Fu, et al.. (2022). Development and validation of a meta-learning-based multi-modal deep learning algorithm for detection of peritoneal metastasis. International Journal of Computer Assisted Radiology and Surgery. 17(10). 1845–1853. 8 indexed citations

10.

Hu, Yan, Yajie Sun, Chao Wan, et al.. (2022). Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research. Journal of Nanobiotechnology. 20(1). 189–189. 35 indexed citations

11.

Meng, Jingshu, Yan Li, Chao Wan, et al.. (2021). Targeting senescence-like fibroblasts radiosensitizes non–small cell lung cancer and reduces radiation-induced pulmonary fibrosis. JCI Insight. 6(23). 81 indexed citations

12.

Dai, Xiaomeng, Yixuan Guo, Yan Hu, et al.. (2021). Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma. Theranostics. 11(7). 3489–3501. 57 indexed citations

13.

Xu, Yaqian, Xiaomeng Dai, Yun Xing, et al.. (2021). The Long-term Effect of Dobutamine on Intrinsic Myocardial Function and Myocardial Injury in Septic Rats with Myocardial Dysfunction. Shock. 56(4). 582–592. 10 indexed citations

14.

Wan, Chao, Yajie Sun, Yu Tian, et al.. (2020). Irradiated tumor cell–derived microparticles mediate tumor eradication via cell killing and immune reprogramming. Science Advances. 6(13). eaay9789–eaay9789. 189 indexed citations

15.

Liu, Haojie, Yan Hu, Yajie Sun, et al.. (2019). Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic–Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy. ACS Nano. 13(11). 12638–12652. 154 indexed citations

16.

Zou, Yibiao, Honglin Jin, Fei Sun, et al.. (2018). Design and Synthesis of a Lead Sulfide Based Nanotheranostic Agent for Computer Tomography/Magnetic Resonance Dual-Mode-Bioimaging-Guided Photothermal Therapy. ACS Applied Nano Materials. 1(5). 2294–2305. 51 indexed citations

17.

Yang, Duomeng, Yun Xing, Xiaomeng Dai, et al.. (2018). A new method for neonatal rat ventricular myocyte purification using superparamagnetic iron oxide particles. International Journal of Cardiology. 270. 293–301. 6 indexed citations

18.

Dai, Xiaomeng, Jun Xue, Jianli Hu, et al.. (2017). Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma. Translational Oncology. 10(4). 511–517. 44 indexed citations

19.

Liu, Yangyang, Feifei Gu, Jinyan Liang, et al.. (2017). The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis. PLoS ONE. 12(3). e0173693–e0173693. 33 indexed citations

20.

Liu, Zi-Hao, Xiaomeng Dai, & Bin Du. (2015). Hes1: a key role in stemness, metastasis and multidrug resistance. Cancer Biology & Therapy. 16(3). 353–359. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact